Pages that link to "Q33295105"

The following pages link to Digitized fluorescent RFLP analysis (fRFLP) as a universal method for comparing genomes of culturable dsDNA viruses: application to bacteriophages (Q33295105):

Displaying 13 items.

• Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials (Q33419859) (← links)
• Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii (Q35222732) (← links)
• Quality and safety requirements for sustainable phage therapy products (Q35674419) (← links)
• Isolation and characterization of T7-like lytic bacteriophages infecting multidrug resistant Pseudomonas aeruginosa isolated from Egypt (Q38984331) (← links)
• Bacterial cell-to-cell signaling promotes the evolution of resistance to parasitic bacteriophages. (Q40279151) (← links)
• Bacterial competition and quorum-sensing signalling shape the eco-evolutionary outcomes of model in vitro phage therapy (Q40356497) (← links)
• Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates (Q40421266) (← links)
• High diversity and novel species of Pseudomonas aeruginosa bacteriophages. (Q41820294) (← links)
• Phages can constrain protist predation-driven attenuation of Pseudomonas aeruginosa virulence in multienemy communities. (Q41885251) (← links)
• Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae. (Q42012908) (← links)
• Bacteriophage Production in Compliance with Regulatory Requirements (Q50100571) (← links)
• Cross-resistance is modular in bacteria-phage interactions (Q57040708) (← links)
• Rapid evolution of generalized resistance mechanisms can constrain the efficacy of phage-antibiotic treatments (Q57825242) (← links)